Analyze Diet

Topic:Pharmacology

Pharmacology in horses involves the study and application of drugs and medications to diagnose, treat, and prevent diseases and conditions in equine species. This field encompasses the understanding of pharmacokinetics and pharmacodynamics specific to horses, including how drugs are absorbed, distributed, metabolized, and excreted by the equine body. Commonly studied pharmacological agents in horses include non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, sedatives, and anthelmintics. Research in equine pharmacology focuses on determining appropriate dosages, understanding drug interactions, and minimizing adverse effects. This page compiles peer-reviewed research studies and scholarly articles that investigate the efficacy, safety, and regulatory aspects of pharmacological interventions in equine veterinary practice.
Endometrial tissue concentrations of enrofloxacin after intrauterine administration to mares.
Veterinary research communications    September 6, 2002   Volume 26, Issue 5 371-380 doi: 10.1023/a:1016242812772
Fumuso E, Checura C, Losinno L, Soto P, Sánchez S.Endometritis in mares is a common cause of infertility. Conventional treatments of the disease have mostly been unsuccessful, so new therapeutic alternatives need to be investigated. This study evaluated the uterine disposition and plasma pharmacokinetic behaviour of a commercial formulation of enrofloxacin (EFX) given by the intrauterine (i.u.) route (2.5 mg/kg) in healthy mares. In order to evaluate the uterine inflammatory response, an initial histopathological study assessing polymorphonuclear cell infiltration was carried out in 20 mares over a 14-day period after treatment. In a second s...
Effects of anti-arthritic drugs on proteoglycan synthesis by equine cartilage.
Journal of veterinary pharmacology and therapeutics    September 6, 2002   Volume 25, Issue 4 289-298 doi: 10.1046/j.1365-2885.2002.00404.x
Frean SP, Cambridge H, Lees P.The concentration-effect relationships of phenylbutazone, indomethacin, betamethasone, pentosan polysulphate (PPS) and polysulphated glycosaminoglycan (PSGAG), on proteoglycan synthesis by equine cultured chondrocytes grown in monolayers, and articular cartilage explants were measured. The effect of PSGAG on interleukin-1beta induced suppression of proteogycan synthesis was also investigated. Proteoglycan synthesis was measured by scintillation assay of radiolabelled sulphate (35SO4) incorporation. Polysulphated glycosaminoglycan and PPS stimulated proteoglycan synthesis in chondrocyte monolay...
Effects of a P2Y(12) receptor antagonist on the response of equine platelets to ADP. Comparison with human platelets.
Research in veterinary science    September 3, 2002   Volume 73, Issue 2 171-175 doi: 10.1016/s0034-5288(02)00096-6
Mateos-Trigos G, Evans RJ, Heath MF.Horses show susceptibility to platelet-related disorders. Equine platelets differ from human platelets in some of their responses, so information available about human platelets must be validated in the horse. Aggregation of platelets by ADP involves both P2Y(1) and P2Y(12) receptors on the platelet surface. We have compared the effect of the P2Y(12) antagonist, AR-C67085, on equine and human platelets in vitro using turbidimetric aggregometry to measure the rate and final extent of aggregation. Aggregation profiles, concentration-response curves and pA(2) values show that the rate of aggregat...
Effects of P2Y(1) and P2Y(12) receptor antagonists on ADP-induced shape change of equine platelets: comparison with human platelets.
Platelets    August 22, 2002   Volume 13, Issue 5-6 285-292 doi: 10.1080/0953710021000007258
Mateos-Trigos G, Evans RJ, Heath MF.Platelet activation by adenosine 5' -diphosphate (ADP) is via both P2Y(1 )and P2Y(12) receptors and leads to shape change and aggregation. The effects on ADP-induced platelet shape change of two P2Y(1) antagonists, adenosine 3'-phosphate, 5'-phosphosulfate (A3P5PS) and 2-deoxy-N(6)-methyladenosine 3', 5'-diphosphate (MRS-2179) and a P2Y(12) antagonist 2-propylthio-D-beta,gamma-dichloromethylene-adenosine 5'-triphosphate (AR-C67085MX) were determined by turbidimetric aggregometry and scanning electron microscopy (SEM) on equine and human platelets. The platelet aggregation was inhibited during ...
Strategies to improve the ovarian response to equine pituitary extract in cyclic mares.
Theriogenology    August 17, 2002   Volume 58, Issue 1 151-164 doi: 10.1016/s0093-691x(02)00902-0
Scoggin CF, Meira C, McCue PM, Carnevale EM, Nett TM, Squires EL.Equine pituitary extract (EPE) has been reported to induce heightened follicular development in mares, but the response is inconsistent and lower than results obtained in ruminants undergoing standard superovulatory protocols. Three separate experiments were conducted to improve the ovarian response to EPE by evaluating: (1) effect of increasing the frequency or dose of EPE treatment; (2) use of a potent gonadotropin-releasing hormone agonist (GnRH-a) prior to EPE stimulation; (3) administration of EPE twice daily in successively decreasing doses. In the first experiment, 50 mares were randoml...
Serum concentrations of keratan sulfate, osteocalcin, and pyridinoline crosslinks after oral administration of glucosamine to standardbred horses during race training.
American journal of veterinary research    August 13, 2002   Volume 63, Issue 8 1106-1110 doi: 10.2460/ajvr.2002.63.1106
Caron JP, Peters TL, Hauptman JG, Eberhart SW, Orth MW.To determine the effects of orally administered glucosamine on concentrations of markers of bone and cartilage metabolism in Standardbred horses during race training. Methods: Twenty 16- to 20-month-old Standardbreds beginning race training. Methods: Horses were randomly assigned to 2 groups. One group received glucosamine hydrochloride (4 g, PO, q 12 h), and the second (control) group received glucose (4 g, PO, q 12 h). Serum samples were obtained prior to onset of the study (baseline) and at regular intervals for 48 weeks for determination of concentrations of keratan sulfate (KS), osteocalc...
Effects of anti-arthritis preparations on gene expression and enzyme activity of cyclooxygenase-2 in cultured equine chondrocytes.
American journal of veterinary research    August 13, 2002   Volume 63, Issue 8 1134-1139 doi: 10.2460/ajvr.2002.63.1134
Tung JT, Venta PJ, Eberhart SW, Yuzbasiyan-Gurkan V, Alexander L, Caron JP.To determine the effects of recombinant equine interleukin -1beta (reIL-1beta) and 4 anti-inflammatory compounds on the expression and activity of cyclooxygenase (COX)-2 in cultured equine chondrocytes. Methods: Articular cartilage from 9 young adult horses. Methods: Reverse transcriptase-polymerase chain reaction methods were used to amplify a portion of equine COX-2 to prepare a cDNA probe. Northern blot analysis was used to quantify the expression of COX-2 in first-passage cultures of equine articular chondrocytes propagated in media containing dexamethasone (DEX), phenylbutazone (PBZ), pol...
Xylazine-induced attenuation of dorsal displacement of the soft palate associated with epiglottic dysfunction in a horse.
Journal of the American Veterinary Medical Association    August 8, 2002   Volume 221, Issue 3 399-368 doi: 10.2460/javma.2002.221.399
Duggan VE, MacAllister CG, Davis MS.An 18-month-old Quarter Horse filly was evaluated because of dorsal displacement of the soft palate associated with epiglottic dysfunction that caused exercise intolerance and an abnormal respiratory noise. The abnormality of the epiglottis was corrected by use of a sedative dose of xylazine hydrochloride. There was no familial predisposition to hyperkalemic periodic paralysis, which may cause similar laryngopharyngeal signs, and the horse did not respond to administration of acetazolamide. There was no known history of trauma that could have caused neuritis, which has also been suggested as a...
[Influencing respiratory gas analytical lung function parameters by intravenous injection of clenbuterol in horses with chronic lung diseases].
DTW. Deutsche tierarztliche Wochenschrift    August 7, 2002   Volume 109, Issue 7 295-299 
Sander K, Deegen E, Ohnesorge B.In a placebo-controlled drug study data were collected about flow, volume and expiratory CO2-concentration in 13 horses with chronic obstructive pulmonary disease before and until 2.5 h after intravenous injection of clenbuterol. An ultrasonic flow measuring unit and an infrared-CO2-analyser (Spiroson Scientific) were used. functional deadspace and expiratory mixed volume were calculated. In addition the effect on the partial pressure of oxygen (PaO2) and carbon dioxide (PaCO2) in arterial blood was tested and the alveolo-arterial oxygen difference (AaDO2) determined. The volume of the functio...
Nitric oxide synthase inhibition speeds oxygen uptake kinetics in horses during moderate domain running.
Respiratory physiology & neurobiology    August 6, 2002   Volume 132, Issue 2 169-178 doi: 10.1016/s1569-9048(02)00068-x
Kindig CA, McDonough P, Erickson HH, Poole DC.Within the moderate exercise intensity domain, the speed of oxygen uptake (V(O(2))) kinetics at the transition to a higher metabolic rate is thought to be limited by an inertia of the oxidative machinery. Nitric oxide (NO)-induced inhibition of O(2) consumption within the electron transport chain may contribute to this inertia. This investigation tested the hypothesis that a reduction or removal of any such NO effect via infusion of N(omega)-nitro-L-arginine methyl ester (L-NAME; a NOS inhibitor) would speed V(O(2)) kinetics at the onset of moderate exercise. Five Thoroughbred geldings underwe...
Lasalocid toxicosis is inadequately quantified for horses.
Veterinary and human toxicology    July 26, 2002   Volume 44, Issue 4 245-247 
Kronfeld DS.The current estimate of LD50, 21.5 mg/kg BW, for lasalocid in horses is based on an analysis of 8 data from 4 horses that died at dose levels of 15, 21, 22 and 26 mg/kg. This analysis neglected 14 data from another 6 horses that survived at dose levels of 5, 10,14, 18, 19, 25, 29 and 50 mg/kg, and so was biased by selection of data. An examination of all the data indicates they are insufficient to determine the LD50. In contrast, the whole data set suggests a lowest toxic dose of 15 mg/kg, although this estimate was based on only 1 affected animal in 8 tests from 5 to 15 mg/kg in an unbalanced...
Incorrect dose of detomidine.
Journal of the American Veterinary Medical Association    July 18, 2002   Volume 221, Issue 2 192 
Wheat JD.No abstract available
Evaluation of the influence of prostaglandin E2 on recombinant equine interleukin-1beta-stimulated matrix metalloproteinases 1, 3, and 13 and tissue inhibitor of matrix metalloproteinase 1 expression in equine chondrocyte cultures.
American journal of veterinary research    July 18, 2002   Volume 63, Issue 7 987-993 doi: 10.2460/ajvr.2002.63.987
Tung JT, Arnold CE, Alexander LH, Yuzbasiyan-Gurkan V, Venta PJ, Richardson DW, Caron JP.To determine the effects of prostaglandin E2 (PGE2) on recombinant equine interleukin (IL)-1beta-stimulated expression of matrix metalloproteinases (MMP 1, MMP 3, MMP 13) and tissue inhibitor of matrix metalloproteinase 1 (TIMP 1) in vitro. Methods: Cultured equine chondrocytes. Methods: Stationary monolayers of first-passage chondrocytes were exposed to graduated concentrations of PGE2 with or without a subsaturating dose (50 pg/ml) of recombinant equine IL-1beta (reIL-1beta) to induce expression of MMP 1, MMP 3, MMP 13, and TIMP 1, followed by RNA isolation and northern blotting. In subseque...
Use of lufenuron as a treatment for fungal endometritis in four mares.
Journal of the American Veterinary Medical Association    July 18, 2002   Volume 221, Issue 2 266-240 doi: 10.2460/javma.2002.221.266
Hess MB, Parker NA, Purswell BJ, Dascanio JD.Lufenuron, a benzoylphenyl urea derivative, was evaluated as a treatment for endometrial fungal infections in 4 mares. Intrauterine lavage was performed with lufenuron suspended in sterile saline (0.9% NaCl) solution. Cytologic evaluation and fungal culture of the endometrium, as well as subsequent reproductive performance, were used to monitor efficacy of this treatment. Fungal endometritis in mares is associated with infertility. Treatment is often ineffective and costly, and recurrence following treatment is not uncommon. Intrauterine infusions of lufenuron were effective in eliminating fun...
In vitro anion transport alterations and apoptosis induced by phenylbutazone in the right dorsal colon of ponies.
American journal of veterinary research    July 18, 2002   Volume 63, Issue 7 934-941 doi: 10.2460/ajvr.2002.63.934
Richter RA, Freeman DE, Wallig M, Whittem T, Baker GJ.To study the functional and structural responses of the right dorsal colon (RDC) of ponies to phenylbutazone (PBZ) in vitro at a concentration that could be achieved in vivo. Methods: 8 adult ponies. Methods: Short circuit current and conductance were measured in mucosa from the RDC. Tissues incubated with and without HCO3- were exposed to PBZ, bumetanide, or indomethacin. Bidirectional Cl- fluxes were determined. After a baseline flux period, prostaglandin E2 (PGE2) was added to the serosal surfaces and a second flux period followed. Light and transmission electron microscopy were performed. ...
Folate deficiency during treatment with orally administered folic acid, sulphadiazine and pyrimethamine in a horse with suspected equine protozoal myeloencephalitis (EPM).
Equine veterinary journal    July 11, 2002   Volume 34, Issue 3 311-316 doi: 10.2746/042516402776186128
Piercy RJ, Hinchcliff KW, Reed SM.No abstract available
The effect of recombinant equine growth hormone on the biomechanical properties of healing superficial digital flexor tendons in horses.
Veterinary surgery : VS    July 3, 2002   Volume 31, Issue 4 320-324 doi: 10.1053/jvet.2002.33590
Dowling BA, Dart AJ, Hodgson DR, Rose RJ, Walsh WR.To evaluate the effect of recombinant equine growth hormone (rEGH) on the in vitro biomechanical properties of healing superficial digital flexor tendon (SDFT) in horses. Methods: Completely randomized design. Methods: Twelve Standardbred horses, 3 to 7 years of age, with ultrasonographically normal forelimb SDFT. Methods: One week after induction of collagenase (2,000 U) induced superficial flexor tendonitis, horses were randomly divided into groups of 6. One group was administered intramuscular rEGH (10 microg/kg/day for 1 week, then 20 microg/kg/day for 5 weeks), whereas the other group (co...
The effect of equine recombinant growth hormone on second intention wound healing in horses.
Veterinary surgery : VS    July 3, 2002   Volume 31, Issue 4 314-319 doi: 10.1053/jvet.2002.33589
Dart AJ, Cries L, Jeffcott LB, Hodgson DR, Rose RJ.To evaluate the effect of intramuscular administration of recombinant equine growth hormone on healing of full thickness skin wounds on equine limbs. Methods: Experimental. Methods: Nine Standardbred horses. Methods: In study 1, standardized full thickness skin wounds (2.5 x 2.5 cm) were made over the dorsomedial aspect of the mid-cannon bone of 1 forelimb and 1 hindlimb in 9 horses. Wounds were bandaged without treatment (control subjects) and videorecorded twice weekly until healed. Then, in study 2, similar wounds were created on the opposite limbs; 6 horses were administered intramuscular ...
The effects of cAMP modulation upon the adhesion and respiratory burst activity of immune complex-stimulated equine neutrophils.
Veterinary immunology and immunopathology    June 29, 2002   Volume 88, Issue 1-2 65-77 doi: 10.1016/s0165-2427(02)00137-x
Chilcoat CD, Rowlingson KA, Jones SL.Toxic products such as reactive oxygen intermediates released by activated polymorphonuclear neutrophil (PMN) have an important role in the pathophysiology of diseases associated with the deposition of immune complexes (IC) in tissues. IC-induced activation of PMN requires adhesion mediated by integrin adhesion receptors. Of the integrins expressed on PMN, the beta(2) family has been found to be of particular importance for activation of PMN by IC. beta(2) Integrin ligand binding must be activated to enable adhesion to IC. Both activating and inhibitory signals regulate beta(2) integrin ligand...
[Treatment of equine sarcoids with cisplatin in arachid oil: a useful alternative?].
Tijdschrift voor diergeneeskunde    June 21, 2002   Volume 127, Issue 11 350-354 
Spoormakers TJ, Klein WR, van Weeren PR.At the Department of Equine Sciences at Utrecht University a study was performed on the treatment of sarcoids with the cytostatic drug cisplatin. Fourteen horses with 23 sarcoids were treated in the period 2000-2001. Complete regression was seen in 78% of the tumours. No systemic side-effects were encountered. Although treatment was easy to perform, the ALARA (As Low As Reasonably Achievable) principle should be followed when using cytostatics.
Anti-inflammatory agent, dexamethasone, does not affect exercise-induced arterial hypoxemia in Thoroughbreds.
Journal of applied physiology (Bethesda, Md. : 1985)    June 19, 2002   Volume 93, Issue 1 99-106 doi: 10.1152/japplphysiol.01186.2001
Manohar M, Goetz TE, Hassan AS, Depuy T, Humphrey S.In view of the suggestion that pulmonary injury-induced release of histamine and/or other chemical mediators from airway inflammatory and mast cells contribute to the exercise-induced arterial hypoxemia (EIAH) in human athletes, we examined the effects of pretreatment with a potent anti-inflammatory agent, dexamethasone, on EIAH and desaturation of hemoglobin in horses. Seven healthy, sound, exercise-trained Thoroughbreds were studied in the control (no medications) experiments, followed in 7 days by intravenous dexamethasone (0.11 mg.kg(-1).day(-1) for 3 consecutive days) studies. Blood-gas m...
Management of gastrointestinal pain.
The Veterinary clinics of North America. Equine practice    June 18, 2002   Volume 18, Issue 1 133-158 doi: 10.1016/s0749-0739(01)00004-9
Malone E, Graham L.Choice of an analgesic for gastrointestinal pain requires consideration of the cause of the pain, desired duration of pain relief, need for sedation, and potential side effects and toxicity, particularly in light of other drugs being used and effects on the gastrointestinal tract. It is imperative that close monitoring be continued to ensure that surgical lesions or worsening conditions are detected. Recent research in the field may lead to new drugs, drug combinations, and avenues of treatment that minimize the side effects of these drugs while maximizing their efficacy.
Neuromuscular blocking agents.
The Veterinary clinics of North America. Equine practice    June 18, 2002   Volume 18, Issue 1 181-188 doi: 10.1016/s0749-0739(02)00012-3
Martinez EA.In summary, with proper vigilance, neuromuscular blocking agents can be used safely in anesthetized equine patients to optimize conditions for certain surgical procedures. By appropriate use of neuromuscular monitoring techniques and reversal agents, residual blockade and muscle weakness should be avoided, allowing the horse to recover to standing without difficulty. Research is ongoing to develop the ideal muscle relaxant, one that has a rapid onset, predictable duration and recovery times, and negligible hemodynamic effects. As newer agents become available, they should be evaluated for thei...
Alpha-2 adrenergic agonists as analgesics in horses.
The Veterinary clinics of North America. Equine practice    June 18, 2002   Volume 18, Issue 1 39-vi doi: 10.1016/s0749-0739(02)00004-4
Daunt DA, Steffey EP.Administration of alpha-2 agonists to horses produces a variety of behavioral effects (sedation, somnolence, analgesia), and physiological effects. One of the most significant beneficial effects of administering alpha-2 agonists is the degree of analgesia they provide. Alpha-2 agonists have been the mainstay of analgesia for colic pain in horses since their introduction to clinical veterinary medicine. The increased potency of the more recently introduced alpha-2 agonists allows the provision of analgesia for conditions not previously relieved by other drugs. Unfortunately, there are significa...
Traditional and non-traditional uses of anesthetic drugs–an update.
The Veterinary clinics of North America. Equine practice    June 18, 2002   Volume 18, Issue 1 169-179 doi: 10.1016/s0749-0739(01)00008-6
Mama KR.Many new or modified injectable anesthetic techniques are available for use in horses. This increased availability allows the clinician to select the technique most appropriate for the patient and clinical circumstance. The use of sedative and anesthetic drugs in managing a variety of anesthesia-related and unrelated aspects of patient care is also increasing. As we begin to use these techniques in the clinical management of our patients, it is important to remember that, while there are more options, no single anesthetic agent or combination of agents is devoid of undesirable effects. Knowled...
Use of opioids for pain and anesthetic management in horses.
The Veterinary clinics of North America. Equine practice    June 18, 2002   Volume 18, Issue 1 47-60 doi: 10.1016/s0749-0739(02)00011-1
Bennett RC, Steffey EP.REGIONAL ADMINISTRATION: There is limited, but convincing, evidence that epidural administration of morphine and some other mu-agonist opioids consistently relieves regional pain in horses. In addition, this effect is not accompanied by notable undesirable effects. On the other hand, a clinically important analgesic action has not been demonstrated for similarly administered kappa-agonist opioids. There has been little objective data presented to support the analgesic effectiveness of intra-articularly administered opioids in horses. However, the evidence of local opioid receptors legitimately...
Effect of topical ophthalmic latanoprost on intraocular pressure in normal horses.
Veterinary therapeutics : research in applied veterinary medicine    June 7, 2002   Volume 3, Issue 1 72-80 
Davidson HJ, Pinard CL, Keil SM, Brightman AH, Sargeant JM.The ocular effects of latanoprost ophthalmic solution were evaluated in two studies, with eight horses in each study. One eye of each horse was treated with latanoprost ophthalmic solution once daily for 5 days, and the opposite eye received a control solution of sterile eyewash. Intraocular pressure and pupillary diameter were measured daily for 5 days after treatment. Latanoprost had no significant effect on intraocular pressure or pupillary diameter in normal horse eyes compared with control eyes in these studies. Placement of an eyelid nerve block resulted in significantly lower intraocula...
Effect of flunixin meglumine on selected physiologic and performance parameters of athletically conditioned thoroughbred horses subjected to an incremental exercise stress test.
Veterinary therapeutics : research in applied veterinary medicine    June 7, 2002   Volume 3, Issue 1 37-48 
Colahan PT, Bailey JE, Chou CC, Johnson M, Rice BL, Jones GL, Cheeks JP.Twelve clinically sound, healthy, athletically conditioned Thoroughbred horses were subjected to an incremental exercise stress test to determine the effects and period of detection of a single dose of flunixin meglumine (1.1 mg/kg by intravenous injection) in serum and urine by ELISA. Flunixin concentrations, performance, and hematologic and clinical chemical parameters were measured. All horses were rotated through four treatment groups of a Latin-square design providing for each horse to serve as its own control. Flunixin meglumine reduced prostaglandin F(1alpha) and thromboxane concentrati...
Cardiovascular effects of romifidine in the standing horse.
Research in veterinary science    May 25, 2002   Volume 72, Issue 2 123-129 doi: 10.1053/rvsc.2001.0533
Freeman SL, Bowen IM, Bettschart-Wolfensberger R, Alibhai HI, England GC.The cardiovascular effects of romifidine, an alpha-2 adrenoreceptor agonist, were investigated in six horses using two doses (80 and 120 microg kg(-1)) in a cross-over study design. Cardiac index and mixed venous oxygenation were significantly decreased at 15 and 30 minutes after both doses of romifidine. Systemic vascular resistance was significantly increased with romifidine (120 microg kg(-1)). Arterial blood pressure increased initially and then gradually decreased; the doses of decrease was significant at 90 and 120 minutes with romifidine 80 and 120 microg kg(-1). There were minimal diff...
Generation and activity of equine osteoclasts in vitro: effects of the bisphosphonate pamidronate (APD).
Research in veterinary science    May 25, 2002   Volume 72, Issue 2 105-113 doi: 10.1053/rvsc.2001.0523
Gray AW, Davies ME, Jeffcott LB.Equine osteoclast-like cells (OCLs) were generated from the bone marrow (BM) of two ponies and one horse in the presence of RANKL, the receptor activator of NF kappa B ligand and macrophage colony-stimulating factor (M-CSF). The phenotype of these cells was confirmed by demonstration of characteristics typical of osteoclasts (OCs) including: the expression of tartrate-resistant acid phosphatase (TRAP), the vitronectin receptor (VNR) and the calcitonin receptor (CTR), the demonstration of responsiveness to calcitonin (CT) and the ability to form resorption lacunae on ivory slices and calcium ph...
1 81 82 83 84 85 172